Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlotte H Clarke

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Chemistry and Laboratory Medicine|November 29, 2005
SELDI-TOF-MS proteomics of breast cancerCharlotte H Clarke, Julie A Buckley, Eric T Fung
Methods in Molecular Biology (Clifton, N.J.)|November 16, 2011
Optimized conditions for a quantitative SELDI TOF MS protein assayLee Lomas, Charlotte H Clarke, Vanitha Thulasiraman, et al.
Gynecologic Oncology|June 29, 2011
Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancerCharlotte H Clarke, Christine Yip, Donna Badgwell, et al.
Neuroendocrinology|January 26, 2002
Selective estrogen receptor modulator effects in the rat brainWenxia Zhou, Nina Koldzic-Zivanovic, Charlotte H Clarke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 21, 2016
Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian CancerArchana R Simmons, Charlotte H Clarke, Donna B Badgwell, et al.
Autophagy|June 1, 2014
DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cellsZhen Lu, Maria T Baquero, Hailing Yang, et al.
Cancer Informatics|May 10, 2011
Reproducibility of SELDI Spectra Across Time and LaboratoriesLixia Diao, Charlotte H Clarke, Kevin R Coombes, et al.
Breast Cancer Research and Treatment|February 5, 2005
Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometryTimothy M Pawlik, Herbert Fritsche, Kevin R Coombes, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Chemistry and Laboratory Medicine|November 29, 2005
SELDI-TOF-MS proteomics of breast cancerCharlotte H Clarke, Julie A Buckley, Eric T Fung
Methods in Molecular Biology (Clifton, N.J.)|November 16, 2011
Optimized conditions for a quantitative SELDI TOF MS protein assayLee Lomas, Charlotte H Clarke, Vanitha Thulasiraman, et al.
Gynecologic Oncology|June 29, 2011
Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancerCharlotte H Clarke, Christine Yip, Donna Badgwell, et al.
Neuroendocrinology|January 26, 2002
Selective estrogen receptor modulator effects in the rat brainWenxia Zhou, Nina Koldzic-Zivanovic, Charlotte H Clarke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 21, 2016
Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian CancerArchana R Simmons, Charlotte H Clarke, Donna B Badgwell, et al.
Autophagy|June 1, 2014
DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cellsZhen Lu, Maria T Baquero, Hailing Yang, et al.
Cancer Informatics|May 10, 2011
Reproducibility of SELDI Spectra Across Time and LaboratoriesLixia Diao, Charlotte H Clarke, Kevin R Coombes, et al.
Breast Cancer Research and Treatment|February 5, 2005
Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometryTimothy M Pawlik, Herbert Fritsche, Kevin R Coombes, et al.
Pageof 1